VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.12 Cr | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-3.12 Cr |
| Mar2025 | ₹-1.02 Cr |
| Mar2024 | ₹-1.08 Cr |
| Mar2023 | ₹-0.57 Cr |
| Mar2022 | ₹-9.48 Cr |
How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.12 Cr | Negative | |
| Mar2025 | ₹-1.02 Cr | Negative | |
| Mar2024 | ₹-1.08 Cr | Negative | |
| Mar2023 | ₹-0.57 Cr | Negative | |
| Mar2022 | ₹-9.48 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,162.8 Cr | -6.2% | 5.9% | 258.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -6.2% |
5.9% |
258.1% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses